Trial
NCT05411679
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
Phase IIWITHDRAWNEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Ellipses Pharma
Collaborators
—
Condition
Gastric Cancer
Intervention
EP0057
Why stopped
Futility analysis decision to terminate EP0057 compound and all Ellipses sponsored studies involving EP0057.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-12